GFM
GPCR icon

GF Fund Management’s Structure Therapeutics GPCR Stock Holding History

GF Fund Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.6K Buy
1,651
+151
+10% +$6.68K ﹤0.01% 345
2026
Q1 		$72.3K Buy
1,500
+188
+14% +$12.9K ﹤0.01% 364
2025
Q4 		$91.3K Buy
1,312
+34
+3% +$1.39K ﹤0.01% 351
2025
Q3 		$35.8K Sell
1,278
-247
-16% -$4.92K ﹤0.01% 428
2025
Q2 		$31.6K Hold
1,525
– – ﹤0.01% 455
2025
Q1 		$26.4K Buy
1,525
+274
+22% +$6.71K ﹤0.01% 474
2024
Q4 		$33.9K Buy
+1,251
New +$44.4K ﹤0.01% 427

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

GF Fund Management's GPCR Position: Q2 2026 in Review

GF Fund Management increased its Structure Therapeutics (GPCR) stake by 10% in Q2 2026, buying an estimated $6.68K and bringing the position to 1,651 shares worth $88.6K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

GF Fund Management first reported a position in GPCR in Q4 2024 and has held it in 7 quarters since. The position peaked at $91.3K in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • GF Fund Management held 1,651 shares of Structure Therapeutics worth $88.6K as of Q2 2026.
  • GF Fund Management bought 151 Structure Therapeutics shares in Q2 2026, an estimated $6.68K.
  • Structure Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #345 holding.
  • GF Fund Management first reported a position in Structure Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Structure Therapeutics position peaked at $91.3K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.